Complex Regional Pain Syndrome: Analgesic Outcome

StatusCompleted
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Lead sponsor: Ciusss de L'Est de l'Île de Montréal to Ciusss de L'Est de l'Île de Montréal Show 6 more changesShow less
    • Trial completed
    • Primary completion date changed from estimate of Jun 2026 to May 1, 2026
    • Enrollment target: estimated 200 to confirmed 201
    • Study completion date changed from estimate of Jun 2026 to Jun 1, 2026
    • Study description expanded, about 41 words
    • Eligibility criteria expanded, about 4 words
  2. Minor Trial status: Not Yet Recruiting to Active, Not Recruitingv3 Show 4 more changesShow less
    • Primary and study completion dates: May 2026 to Jun 2026
    • Start date changed from estimate of Nov 2025 to Nov 15, 2025
    • Study description shortened, about 287 words
    • Site contacts updated at 2 of 2 sites
  3. Minor Eligibility criteria shortened, about 30 words
    • Study description revised
    v2
  4. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This retrospective observational study aims to describe the use and analyze the effectiveness of various analgesic interventions in patients diagnosed with Complex Regional Pain Syndrome (CRPS) at the Pain Management Center of Hôpital Maisonneuve-Rosemont (HMR) between January 2020 and October 2025. Background: Complex Regional Pain Syndrome is a chronic pain condition characterized by severe, persistent pain accompanied by sensory, vasomotor, sudomotor, and motor/trophic changes, often following trauma or surgery. Despite established diagnostic criteria (Budapest criteria), its pathophysiology remains poorly understood, and evidence-based treatments are limited. While multidisciplinary functional rehabilitation remains the cornerstone of management, various analgesic interventions are used to facilitate recovery when medications fail to adequately control pain. Common interventions include: * Plexus or peripheral nerve blocks (brachial or sciatic, with or without adjuvants such as dexamethasone or dexmedetomidine) * Intravenous ketamine infusions * Sympathetic blocks (stellate or lumbar) * Intravenous pamidronate infusions Although all these techniques are used in clinical practice, their relative efficacy and predictive factors for success remain unknown. Clinicians rely on experience rather than data-driven guidance to select an initial intervention. Identifying factors such as CRPS subtype or symptom duration that predict analgesic response could improve treatment efficiency and functional recovery. Methods: This is a retrospective chart review including all adult patients with a CRPS diagnosis established using the Budapest criteria who received at least one eligible analgesic intervention during the study period. Data will be extracted from electronic medical records by the research team. Exclusion criteria include incomplete clinical documentation or missing information regarding the first consultation, intervention type, or analgesic outcome. Collected variables include demographics, medications, CNESST (workers' compensation) status, PTSD diagnosis, trauma type, CRPS characteristics (affected limb, type, subtype, symptom duration), details of the first intervention (technique, dose, use of adjuvants), analgesic response, and adverse effects.
Trial Details
NCT Number NCT07228949
Lead Sponsor Ciusss de L'Est de l'Île de Montréal
Conditions
(from sponsor)
Chronic Pain, Complex Regional Pain Syndrome
Related terms Chronic Pain, Complex Regional Pain Syndromes
Enrollment 201 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov